Literature DB >> 19752337

Cancer, clots and consensus: new understanding of an old problem.

Gary H Lyman1, Alok A Khorana.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19752337      PMCID： PMC2764390          DOI： 10.1200/JCO.2009.22.3032

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  98 in total

1.  Incidental detection of pulmonary emboli on routine MDCT of the chest.

Authors:  Maria Luigia Storto; Angela Di Credico; Francesca Guido; Anna Rita Larici; Lorenzo Bonomo
Journal:  AJR Am J Roentgenol       Date:  2005-01       Impact factor: 3.959

2.  Evaluation of perioperative fatal pulmonary embolism and death in cancer surgical patients: the MC-4 cancer substudy.

Authors:  Ajay K Kakkar; Sylvia Haas; Helmut Wolf; Albrecht Encke
Journal:  Thromb Haemost       Date:  2005-10       Impact factor: 5.249

3.  Longitudinal evaluation of health plan cost per venous thromboembolism or bleed event in patients with a prior venous thromboembolism event during hospitalization.

Authors:  Michael F Bullano; Vincent Willey; Ole Hauch; Gail Wygant; Alex C Spyropoulos; Lauren Hoffman
Journal:  J Manag Care Pharm       Date:  2005-10

Review 4.  Impact of venous thromboembolism and anticoagulation on cancer and cancer survival.

Authors:  Nicole M Kuderer; Thomas L Ortel; Charles W Francis
Journal:  J Clin Oncol       Date:  2009-09-08       Impact factor: 44.544

Review 5.  The heparins and cancer: review of clinical trials and biological properties.

Authors:  Roberto Castelli; Fernando Porro; Paolo Tarsia
Journal:  Vasc Med       Date:  2004-05       Impact factor: 3.239

6.  The effect of low molecular weight heparin on survival in patients with advanced malignancy.

Authors:  Clara P W Klerk; Susanne M Smorenburg; Hans-Martin Otten; Anthonie W A Lensing; Martin H Prins; Franco Piovella; Paolo Prandoni; Monique M E M Bos; Dick J Richel; Geertjan van Tienhoven; Harry R Büller
Journal:  J Clin Oncol       Date:  2005-02-07       Impact factor: 44.544

Review 7.  Venous thromboembolism in the hematologic malignancies.

Authors:  Anna Falanga; Marina Marchetti
Journal:  J Clin Oncol       Date:  2009-09-14       Impact factor: 44.544

Review 8.  Prevention of thrombosis in ambulatory patients with cancer.

Authors:  Punam Rana; Mark N Levine
Journal:  J Clin Oncol       Date:  2009-09-14       Impact factor: 44.544

Review 9.  Catheter-associated thrombosis in patients with malignancy.

Authors:  Sudeep P Shivakumar; David R Anderson; Stephen Couban
Journal:  J Clin Oncol       Date:  2009-09-08       Impact factor: 44.544

Review 10.  Anticoagulation in the treatment of established venous thromboembolism in patients with cancer.

Authors:  Agnes Y Y Lee
Journal:  J Clin Oncol       Date:  2009-09-08       Impact factor: 44.544
View more
  64 in total

1.  Metastasis as a therapeutic target in prostate cancer: a conceptual framework.

Authors:  Konstantin Stoletov; David Bond; Katie Hebron; Srijan Raha; Andries Zijlstra; John D Lewis
Journal:  Am J Clin Exp Urol       Date:  2014-04

2.  Integrating genetic and gene expression evidence into genome-wide association analysis of gene sets.

Authors:  Qing Xiong; Nicola Ancona; Elizabeth R Hauser; Sayan Mukherjee; Terrence S Furey
Journal:  Genome Res       Date:  2011-09-22       Impact factor: 9.043

Review 3.  Thrombosis and cancer.

Authors:  Annie Young; Oliver Chapman; Carole Connor; Christopher Poole; Peter Rose; Ajay K Kakkar
Journal:  Nat Rev Clin Oncol       Date:  2012-07-10       Impact factor: 66.675

4.  High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy: a large retrospective analysis.

Authors:  Russell A Moore; Nelly Adel; Elyn Riedel; Manisha Bhutani; Darren R Feldman; Nour Elise Tabbara; Gerald Soff; Rekha Parameswaran; Hani Hassoun
Journal:  J Clin Oncol       Date:  2011-08-01       Impact factor: 44.544

5.  High D-dimer levels are associated with poor prognosis in cancer patients.

Authors:  Cihan Ay; Daniela Dunkler; Robert Pirker; Johannes Thaler; Peter Quehenberger; Oswald Wagner; Christoph Zielinski; Ingrid Pabinger
Journal:  Haematologica       Date:  2012-02-27       Impact factor: 9.941

6.  Quantitative estimation of Serum Fibrinogen Degradation Product levels in Oral Premalignant and Malignant lesions.

Authors:  Leena Gharat; Govind P Rathod; Shilpa Kandalgaonkar
Journal:  J Int Oral Health       Date:  2013-10-26

7.  Incidence and Effect of Thromboembolic Events in Radical Cystectomy Patients Undergoing Preoperative Chemotherapy for Muscle-invasive Bladder Cancer.

Authors:  Aditya Bagrodia; Ranjit Sukhu; Andrew G Winer; Eric Levy; Michael Vacchio; Byron Lee; Eugene J Pietzak; Timothy F Donahue; Eugene Cha; Gopa Iyer; Daniel D Sjoberg; Andrew J Vickers; Jonathan E Rosenberg; Dean F Bajorin; Guido Dalbagni; Bernard H Bochner
Journal:  Clin Genitourin Cancer       Date:  2017-08-10       Impact factor: 2.872

8.  Impact of cardiovascular comorbidity on ovarian cancer mortality.

Authors:  Eileen H Shinn; Daniel J Lenihan; Diana L Urbauer; Karen M Basen-Engquist; Alan Valentine; Laura Palmero; Myrshia L Woods; Pooja Patel; Alpa M Nick; Mian M K Shahzad; Rebecca L Stone; Antoinette Golden; Emma Atkinson; Susan K Lutgendorf; Anil K Sood
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-09-17       Impact factor: 4.254

9.  Clinical and prognostic significance of coagulation assays in gastric cancer.

Authors:  Faruk Tas; Rumeysa Ciftci; Leyla Kilic; Murat Serilmez; Senem Karabulut; Derya Duranyildiz
Journal:  J Gastrointest Cancer       Date:  2013-09

10.  Prognostic and predictive value of plasma D-dimer in advanced non-small cell lung cancer patients undergoing first-line chemotherapy.

Authors:  L-P Ge; J Li; Q-L Bao; P Chen; Q Jiang; L-R Zhu
Journal:  Clin Transl Oncol       Date:  2014-07-05       Impact factor: 3.405
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.